How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?
Eur J Hosp Pharm. 2024 Jul 13:ejhpharm-2024-004109. doi: 10.1136/ejhpharm-2024-004109. Online ahead of print. ABSTRACT Congenital pre-extensively drug-resistant tuberculosis is rare, and administration of second-line anti-tuberculosis …